Back

LEP-AD: Language Embedding of Proteins and Attention to Drugs predicts drug target interactions

Daga, A.; Khan, S. A.; Cabrero, D. G.; Hoehndorf, R.; Kiani, N.; Tegner, J.

2023-03-15 bioinformatics
10.1101/2023.03.14.532563 bioRxiv
Show abstract

AO_SCPLOWBSTRACTC_SCPLOWPredicting drug-target interactions is a tremendous challenge for drug development and lead optimization. Recent advances include training algorithms to learn drug-target interactions from data and molecular simulations. Here we utilize Evolutionary Scale Modeling (ESM-2) models to establish a Transformer protein language model for drug-target interaction predictions. Our architecture, LEP-AD, combines pre-trained ESM-2 and Transformer-GCN models predicting binding affinity values. We report new best-in-class state-of-the-art results compared to competing methods such as SimBoost, DeepCPI, Attention-DTA, GraphDTA, and more using multiple datasets, including Davis, KIBA, DTC, Metz, ToxCast, and STITCH. Finally, we find that a pre-trained model with embedding of proteins (the LED-AD) outperforms a model using an explicit alpha-fold 3D representation of proteins (e.g., LEP-AD supervised by Alphafold). The LEP-AD model scales favorably in performance with the size of training data. Code available at https://github.com/adaga06/LEP-AD

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.